TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/1/24 17:59 | 9/30/24 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | Talasaz Amirali | CA | DO | Co-CEO | M.d | 0 | 0.00 | 0 | 11 | 1 | 2,204 | D | ||||||||||||||
7/2/24 16:51 | 6/30/24 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | Talasaz Amirali | CA | DO | Co-CEO | M.d | 0 | 0.00 | 0 | 11 | 1 | 2,199 | D | ||||||||||||||
5/6/24 17:03 | 5/2/24 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | Talasaz Amirali | CA | DO | Co-CEO | M.d | 1,186 | 4.18 | 0 | 284 | 15 | 2,193 | D | ||||||||||||||
4/1/24 17:23 | 3/31/24 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | Talasaz Amirali | CA | DO | Co-CEO | M.d | 0 | 0.00 | 0 | 11 | 1 | 1,909 | D | ||||||||||||||
3/15/23 18:11 | 3/13/23 | GH | Guardant Health, Inc. | DE | Health | Health | Medical Laboratories | Talasaz Amirali | CA | DO | Co-CEO | P.m | 2,501 | 25.79 | 0 | 97 | 5 | 1,951 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |